Personalized drug test for newly diagnosed rheumatoid arthritis
Treatments studied
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This trial tests a personalized approach to find which of four biologic drugs works best for you if methotrexate didn't help or caused side effects. You'll get each drug in turn and track your symptoms to find your best match.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You were recently diagnosed with rheumatoid arthritis and have moderate to severe symptoms (like at least 6 tender and 6 swollen joints).
- You either took methotrexate for at least 12 weeks and it didn't work well enough, or you had to stop because of side effects.
- You have never taken etanercept, adalimumab, upadacitinib, or tocilizumab before.
- You have a C-reactive protein level at least 1 times the normal upper limit.
- You have insurance that takes part in this trial and can do telehealth visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 4 trial studies whether immune-modulator medicines improve symptoms and function in people with rheumatoid arthritis who have knee problems. It may also compare responses in osteoarthritis and healthy volunteers, depending on the group you fit.
This trial tests a new medication (BMS-986454) for people with rheumatoid arthritis who haven't responded well enough to methotrexate. It aims to see if the drug is safe and how it works in the body.
This trial tests a step-by-step plan for treating rheumatoid arthritis when current medicines aren’t controlling the disease. It compares how well a targeted approach works by adjusting treatment for people who need a TNF inhibitor.
This trial studies rheumatoid arthritis (RA) patients starting or adjusting DMARD medicines and looks for signs that predict who responds best. It may help doctors choose more effective treatment sooner.
This trial studies advanced medicines for rheumatoid arthritis (RA) in people whose RA is still active despite several standard treatments. It may help by testing whether a different advanced option can better control symptoms and joint inflammation.
This trial tests different targeted treatments for people with rheumatoid arthritis who have tried one or two biologic or targeted synthetic drugs but still have symptoms. You need to be taking a stable dose of methotrexate.
Hear when a new Arthritis, Rheumatoid trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.